Moderna
MRNA
#1188
Rank
NZ$26.80 B
Marketcap
$69.67
Share price
-0.43%
Change (1 day)
-53.78%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - P/B ratio

P/B ratio as of December 2024 : 1.27

According to Moderna 's latest financial reports the company has a price-to-book ratio of 2.99802.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Moderna - P/B ratio (from 2018 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-311.35-50.64%
2023-12-312.74-24.15%
2022-12-313.61-50.43%
2021-12-317.28-54.9%
2020-12-3116.1188.09%
2019-12-315.6070.78%
2018-12-313.28
2017-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
1.20-5.60%๐Ÿ‡บ๐Ÿ‡ธ USA
5.57 337.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.0229-101.80%๐Ÿ‡บ๐Ÿ‡ธ USA
978 76,889.53%๐Ÿ‡บ๐Ÿ‡ธ USA
4.47 251.66%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
12.7 896.71%๐Ÿ‡บ๐Ÿ‡ธ USA
4.96 290.10%๐Ÿ‡บ๐Ÿ‡ธ USA